Hypertension (high blood pressure) Board decisions

The appeal for an effective date prior to August 10, 2022 for the grant of service connection for hypertension is dismissed as it was previously adjudicated by the Board in June 2023 and has not been appealed to the Court of Appeals for Veterans Claims (CAVC).

The Board denied the claim for service connection of hypertension, finding that there is no evidence to support a link between the condition and active service.

The Board has remanded the Veteran's claims for additional development due to conflicting evidence regarding the onset and causation of his claimed disabilities. The appeals are currently pending.

The Board has decided to remand the case for further development and medical opinions regarding whether hypertension is proximately due or aggravated by a service-connected psychiatric disorder.

The Board has remanded the case due to the need for an addendum opinion regarding the relationship between the Veteran's hypertension and his service-connected obstructive sleep apnea.

The Board has granted service connection for hypertension but denied service connection for a left ankle disability.

The Veteran's hypertension is granted as presumptively related to his in-service herbicide exposure under the PACT Act. The lung disability issue remains pending and will be remanded for further examination.

The Board has determined that the Veteran's hypertension is related to his service in Vietnam and has granted service connection based on the PACT Act. However, further development is needed as the October 2021 VA examination is inadequate.

The Board denied service connection for hypertension, finding that the Veteran's current diagnosis was not related to his active military service.

The Veteran's PTSD is granted a 100% rating, and the appeal for increased ratings of plantar fasciitis, bilateral hearing loss, service connection for human T-cell lymphotropic virus antibody, and hypertension are dismissed. The appeal for TDIU is denied.

The Veteran's hypertension is currently rated at 10 percent, and the Board found that it does not meet the criteria for a higher rating as his diastolic pressure was predominantly less than 110 or systolic pressure less than 200.

The Veteran's claims for earlier effective dates for service connection are denied as the earliest possible effective dates have been assigned.

The Board has dismissed all issues related to earlier effective dates and initial disability ratings for various peripheral neuropathies, hypertension, and erectile dysfunction.

The Board has decided to remand the case due to a failure to obtain private medical records and to address whether further development is needed, including a VA examination.

The Board has granted service connection for DMII, hypertension, bilateral cataracts, and ED as secondary to DMII. The Veteran's peripheral neuropathy of the upper and lower extremities is remanded due to a duty-to-assist error.

The Board has dismissed the claims for service connection for trace hyperopia and presbyopia. The initial compensable rating claim for hearing loss was denied, while the issues of service connection for sleep apnea and hypertension are remanded.

The Veteran's service-connected disabilities rendered him unable to secure and follow substantially gainful employment as of January 6, 2015.

The Veteran's service connection for chronic fibroadenosis of the breast, heart disability (including sinus bradycardia and second-degree AV block type I), hypertension, and atypical chest wall pain is restored. The issues of service connection for a heart disability secondary to thyroid disability and for thyroid disability secondary to heart disability are remanded.

The Veteran's hypertension service connection was granted via the PACT Act, but a VA examination is needed to determine the current severity of his condition.

The Board has granted service connection for hypertension, diabetes mellitus type II, LLE and RLE peripheral diabetic neuropathy as secondary to the Veteran's service-connected diabetes mellitus type II. The decision is based on presumed exposure to herbicides during service.